Guideline
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Guideline
- Guideline
- KASL clinical practice guidelines for management of autoimmune hepatitis 2022
- Clin Mol Hepatol. 2023;29(3):542-592. Published online May 3, 2023
-
View: 4320 Download: 318 Web of Science: 2 Crossref: 5
- Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association
- Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
- Clin Mol Hepatol. 2023;29(3):521-541. Published online July 1, 2023
-
View: 3512 Download: 213 Web of Science: 8 Crossref: 9
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022
-
View: 14072 Download: 743 Web of Science: 116 Crossref: 119
- KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940
-
View: 11411 Download: 609 Web of Science: 44 Crossref: 52
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
- Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021
-
View: 19063 Download: 1,235 Web of Science: 154 Crossref: 166
- KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
- Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020
-
View: 21893 Download: 1,361 Web of Science: 77 Crossref: 74
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
